Indication of anthra[2,1,c][1,2,5]thiadiazole-6,11-dione compound in alleviating pain
US9192602B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2014 |
| Grant date | Nov 24, 2015 |
| Priority date | — |
| Expiry date | Sep 16, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are anthra[2,1-c][1,2,5]thiadiazole-6,11-dione compounds and pharmaceutical composition thereof. The compounds of the invention have been demonstrated as having analgesic effects and therefore may be applicable for use as a novel agent in relieving acute or chronic pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.